Management of chronic hepatitis B in patients from special populations

Ching-Lung Lai; Man-Fung Yuen

doi:10.1101/cshperspect.a021527

Management of chronic hepatitis B in patients from special populations

Cold Spring Harb Perspect Med. 2015 Jun 1;5(6):a021527. doi: 10.1101/cshperspect.a021527.

Authors

Ching-Lung Lai¹, Man-Fung Yuen¹

Affiliation

¹ Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong 999077, China.

Abstract

Here we review the management of chronic hepatitis B (CHB) in four special categories of patients: CHB in pregnancy, in patients on immunosuppressive treatments, in patients undergoing liver transplantation, and in patients coinfected with human immunodeficiency virus (HIV) or hepatitis C virus (HCV).

Publication types

Review

MeSH terms

Antibodies, Monoclonal / adverse effects
Antiviral Agents / therapeutic use
Coinfection / complications
Female
HIV Infections / complications
Hepatitis B, Chronic / therapy*
Hepatitis C, Chronic / complications
Humans
Immune Reconstitution Inflammatory Syndrome / etiology
Immune Reconstitution Inflammatory Syndrome / prevention & control
Immunosuppression Therapy / adverse effects
Immunosuppressive Agents / adverse effects
Infectious Disease Transmission, Vertical / prevention & control
Liver Transplantation
Pregnancy
Pregnancy Complications, Infectious / virology
Recurrence
Tumor Necrosis Factor-alpha / adverse effects
Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

Antibodies, Monoclonal
Antiviral Agents
Immunosuppressive Agents
Tumor Necrosis Factor-alpha